Capricor (CAPR) Moves 12.0% Higher: Will This Strength Last?
Capricor (CAPR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·2h ago
More News
PHG or LMAT: Which Is the Better Value Stock Right Now?
PHG vs. LMAT: Which Stock Is the Better Value Option?
Zacks·8d ago
Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think "Yes"
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
Zacks·2mo ago
NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve
enVVeno Medical shares plunge after the FDA rejects its VenoValve PMA, citing insufficient trial data and safety concerns tied to the surgical procedure.
Zacks·2mo ago
NVCR Stock Slips Despite PMA Application to Treat Pancreatic Cancer
NovoCure submits a PMA to the FDA for TTFields therapy in pancreatic cancer, aiming to expand its oncology reach.
Zacks·2mo ago
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks·3mo ago
LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of +5.26% and +2.53%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
PAHC vs. LMAT: Which Stock Is the Better Value Option?
Zacks·3mo ago
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular
Latest Ratings for LMAT
DateFirmActionFromTo Sep 2021JefferiesInitiates Coverage OnBuy Aug 2021Roth CapitalMaintainsNeutral May 2021Roth CapitalMaintainsNeutral
View More Analyst Ratings for...
Benzinga·1y ago
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular
Latest Ratings for LMAT
DateFirmActionFromTo Sep 2021JefferiesInitiates Coverage OnBuy Aug 2021Roth CapitalMaintainsNeutral May 2021Roth CapitalMaintainsNeutral
View More Analyst Ratings for...